Multitrace-4 Neonatal Drug Interactions
Currently displaying 100 drugs known to have a minor interaction with Multitrace-4 Neonatal (trace elements).
- 4 major drug interactions
- 84 moderate drug interactions
- 100 minor drug interactions
Minor interactions with Multitrace-4 Neonatal (trace elements)
Note: Showing generic names only.
A
- abatacept
- abemaciclib
- abrocitinib
- adalimumab
- alefacept
- anakinra
- anifrolumab
- anti-thymocyte globulin (rabbit)
- avacopan
- azathioprine
B
- baricitinib
- basiliximab
- beclomethasone
- belatacept
- belimumab
- betamethasone
- bimekizumab
- blinatumomab
- brodalumab
- budesonide
C
D
- daclizumab
- danicopan
- deflazacort
- deucravacitinib
- dexamethasone
- dimethyl fumarate
- diroximel fumarate
- dupilumab
E
F
G
H
I
- imetelstat
- infliximab
- iptacopan
- iron bisglycinate
- iron polysaccharide
- iron protein succinylate
- ixekizumab
L
M
N
O
P
R
S
T
- tacrolimus
- temsirolimus
- teplizumab
- teriflunomide
- tildrakizumab
- tocilizumab
- tofacitinib
- tralokinumab
- triamcinolone
U
V
Z
Multitrace-4 Neonatal disease interactions
There are 4 disease interactions with Multitrace-4 Neonatal (trace elements) which include:
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.